The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Annual report and notice of AGM

14 May 2019 16:24

RNS Number : 0190Z
Circassia Pharmaceuticals Plc
14 May 2019
 

For immediate release

 

Circassia Pharmaceuticals plc

 

Annual Report and Accounts for the year ended 31 December 2018 and Notice of 2019 Annual General Meeting

 

14 May 2019

 

Circassia Pharmaceuticals plc announces that its Annual Report and Accounts for the year ended 31 December 2018 and Notice of 2019 Annual General Meeting have been published on the Company's website: www.circassia.com. Additionally, these documents have been posted, or otherwise made available, to shareholders.

 

The Annual General Meeting will be held at 12.00 midday on Friday 7 June 2019 at the Company's offices: Northbrook House, Robert Robinson Avenue, Oxford, OX4 4GA.

 

 

Contacts

Circassia

Steven Harris, Chief Executive Officer Tel: +44 (0) 1865 405 560

Julien Cotta, Chief Financial Officer

Rob Budge, Corporate Communications

 

Peel Hunt (Nominated Adviser and Joint Broker)

James Steel / Dr Christopher Golden Tel: +44 (0) 20 7418 8900

 

Numis Securities (Joint Broker)

James Black / Freddie Barnfield Tel: +44 (0) 20 7260 1000

 

FTI Consulting

Simon Conway / Ciara Martin Tel: +44 (0) 20 3727 1000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUSUVRKRAVAAR

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.